Sedana Medical AB (publ), Fourth Quarter and Year-end Report
Registration application submitted in the EU – strong sales increase as a result of COVID-19Financial Summary This year-end report has been prepared in accordance with IFRS, and comparative periods have been restated. October-December 2020 · Net sales amounted to MSE 46 (20), equivalent to an increase of 129% on the same period of 2019. · Earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to SEK -5 (-4), equivalent to an EBITDA margin of -10% (-20%). · Earnings before interest and taxes (EBIT) amounted to MSEK -7 (-5), equivalent to an EBIT